Bisphosphonates may potentiate radiation effects: A new approach in cancer treatment?

Biochemical and Biophysical Research Communications

Volumn 336, Issue 2, 2005, Pages 373-374

  Ural, A Ugur ^a   Avcu, Ferit ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; RADIOSENSITIZING AGENT; ZOLEDRONIC ACID;

ANTINEOPLASTIC ACTIVITY; CANCER RADIOTHERAPY; CYTOTOXICITY; DOSE RESPONSE; DRUG POTENTIATION; HUMAN; PRIORITY JOURNAL; RADIOSENSITIZATION; SHORT SURVEY;

ANIMALS; DIPHOSPHONATES; HUMANS; NEOPLASMS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS;

EID: 24644487401     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.07.120     Document Type: Short Survey

References (16)

1. J.F. Bukowski, C.D. Christopher, and D. Hiranmoy Alternative bisphosphonate targets and mechanisms of action Biochem. Biophys. Res. Commun. 328 2005 746 750
2. U. Vogt, K.P. Bielawski, U. Bosse, and C.M. Schlotter Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/ metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid Oncol. Rep. 12 2004 1109 1114
3. A.U. Ural, M.I. Yilmaz, F. Avcu, A. Pekel, M. Zerman, O. Nevruz, A. Sengul, and A. Yalcin The bisphosphonate zoledronic acid induces cytotoxicity in human myeloma cell lines with enhancing effects of dexamethasone and thalidomide Int. J. Hematol. 78 2003 443 449
4. A.U. Ural, and F. Avcu Evolving therapeutic role of bisphosphonates in multiple myeloma Br. J. Cancer 93 2005 267 268
5. F. Avcu, A.U. Ural, M.I. Yilmaz, A. Ozcan, T. Ide, B. Kurt, and A. Yalcin The bisphosphonate zoledronic acid inhibits the development of plasmacytoma induced in BALB/c mice by intraperitoneal injection of pristane Eur. J. Haematol. 74 2005 496 500
6. E. Algur, R.M. Macklis, and U.O. Hafeli Synergistic cytotoxic effects of zoledronic acid and radiation in human prostate cancer and myeloma cell lines Int. J. Radiat. Oncol. Biol. Phys. 61 2005 535 542
7. S. Matsumoto, S. Kimura, H. Segawa, J. Kuroda, T. Yuasa, K. Sato, M. Nogawa, F. Tanaka, T. Maekawa, and H. Wada Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell lines Lung Cancer 47 2005 31 39
8. L. Milas, N.R. Hunter, K.A. Mason, B. Kurdoglu, and L.J. Peters Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel Cancer Res. 54 1994 3506 3510
9. B. Kurdoglu, N. Cheong, J. Guan, B.W. Corn, W.J. Curran, and G. Iliakis Jr. Apoptosis as a predictor of paclitaxel-induced radiosensitization in human tumor cell lines Clin. Cancer Res. 5 1999 2580 2587
10. N. Gupta, L.J. Hu, and D.F. Deen Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation Int. J. Radiat. Oncol. Biol. Phys. 37 1997 885 895
11. J. Kuroda, S. Kimura, H. Segawa, K. Sato, S. Matsumoto, M. Nogawa, T. Yuasa, Y. Kobayashi, T. Yoshikawa, O.G. Ottmann, and T. Maekawa p53-independent anti-tumor effects of the nitrogen-containing bisphosphonate zoledronic acid Cancer Sci. 95 2004 186 192
12. J. Sun, Y. Qian, A.D. Hamilton, and S.M. Sebti Ras CAAX peptidometric FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-Ras mutation and p53 deletion Cancer Res. 55 1995 4243 4247
13. X. Li, L. Liu, J.C. Tupper, D.D. Bannerman, R.K. Winn, S.M. Sebti, A.D. Hamilton, and J.M. Harlan Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells J. Biol. Chem. 277 2002 15309 15316
14. M. Salomo, J. Jurlander, L.B. Nielsen, and P. Gimsing How myeloma cells escape bisphosphonate-mediated killing: development of specific resistance with preserved sensitivity to conventional chemotherapeutics Br. J. Haematol. 122 2003 202 210
15. W.G. McKenna, and R.J. Muschel Targeting tumor cells by enhancing radiation sensitivity Genes Chromosomes Cancer 38 2003 330 338
16. E.J. Bernhard, G. Kao, A.D. Cox, S.M. Sebti, A.D. Hamilton, R.J. Muschel, and W.G. McKenna The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts Cancer Res. 56 1996 1727 1730